Effects of oral maintenance chemotherapy and predictive value of circulating EBV DNA in metastatic nasopharyngeal carcinoma

ConclusionsOral maintenance chemotherapy with S1 or capecitabine can improve OS in mNPC. Posttreatment EBV ‐DNA was not only an independent prognosis factor for mNPC but also can screen out beneficiaries of maintenance chemotherapy.

Source: Cancer Medicine - February 25, 2020 Category: Cancer & Oncology Authors: Han Zhou, Tianzhu Lu, Qiaojuan Guo, Yan Chen, Mengwei Chen, Yansong Chen, Yingying Lin, Chuanben Chen, Liqin Ma, Yun Xu, Shaojun Lin, Jianji Pan Tags: ORIGINAL RESEARCH Source Type: research